The title compound, a pseudopeptide, methyl (2S)-3-(4-hydroxyphenyl)-2-[(3S
)-4-(tert-butoxycarbonyl)-3-(4-hydroxybenzyl)-2-oxopiperazin-1-yl]propionat
e, C26H32N2O7, was crystallized from an H2O/methanol solution. The two N-su
bstituted chains on the piperazin-2-one (MKP) ring lie in the quasi-equator
ial position and the third chain lies in the quasi-axial position. Each sid
e chain on the tyrosines is located opposite the MKP ring. The MKP ring has
a pseudo-chair form.